Antonio Regalado is a biotechnology journalist at MIT Technology Review, specializing in reporting on cutting-edge scientific advances such as rejuvenation technologies, CRISPR, and epigenetic research. He provides critical analysis of biotech startups and industry trends, leveraging his platform to inform and engage a broad audience. With a substantial following, Regalado is recognized for his expertise in biotech journalism and science communication.

‌